These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31486023)

  • 1. N-Benzyl-(2,5-dioxopyrrolidin-1-yl)propanamide (AS-1) with Hybrid Structure as a Candidate for a Broad-Spectrum Antiepileptic Drug.
    Kamiński K; Socała K; Zagaja M; Andres-Mach M; Abram M; Jakubiec M; Pieróg M; Nieoczym D; Rapacz A; Gawel K; Esguerra CV; Latacz G; Lubelska A; Szulczyk B; Szewczyk A; Łuszczki JJ; Wlaź P
    Neurotherapeutics; 2020 Jan; 17(1):309-328. PubMed ID: 31486023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of new hybrid anticonvulsants derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide derivatives.
    Kamiński K; Rapacz A; Łuszczki JJ; Latacz G; Obniska J; Kieć-Kononowicz K; Filipek B
    Bioorg Med Chem; 2015 May; 23(10):2548-61. PubMed ID: 25868743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KA-11, a Novel Pyrrolidine-2,5-dione Derived Broad-Spectrum Anticonvulsant: Its Antiepileptogenic, Antinociceptive Properties and in Vitro Characterization.
    Socała K; Mogilski S; Pieróg M; Nieoczym D; Abram M; Szulczyk B; Lubelska A; Latacz G; Doboszewska U; Wlaź P; Kamiński K
    ACS Chem Neurosci; 2019 Jan; 10(1):636-648. PubMed ID: 30247871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and anticonvulsant activity of new hybrid compounds derived from N-phenyl-2-(2,5-dioxopyrrolidin-1-yl)-propanamides and -butanamides.
    Kamiński K; Rapacz A; Filipek B; Obniska J
    Bioorg Med Chem; 2016 Jul; 24(13):2938-2946. PubMed ID: 27211245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New hybrid molecules with anticonvulsant and antinociceptive activity derived from 3-methyl- or 3,3-dimethyl-1-[1-oxo-1-(4-phenylpiperazin-1-yl)propan-2-yl]pyrrolidine-2,5-diones.
    Kamiński K; Zagaja M; Rapacz A; Łuszczki JJ; Andres-Mach M; Abram M; Obniska J
    Bioorg Med Chem; 2016 Feb; 24(4):606-18. PubMed ID: 26746343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Search for New Anticonvulsants in a Group of (2,5-Dioxopyrrolidin-1-yl)(phenyl)Acetamides with Hybrid Structure-Synthesis and In Vivo/In Vitro Studies.
    Abram M; Jakubiec M; Rapacz A; Mogilski S; Latacz G; Kamiński RM; Kamiński K
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of docosahexaenoic acid on anticonvulsant activity of valproic acid and lamotrigine in animal seizure models.
    Gavzan H; Sayyah M; Sardari S; Babapour V
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Oct; 388(10):1029-38. PubMed ID: 26018398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of (
    Abram M; Jakubiec M; Reeb K; Cheng MH; Gedschold R; Rapacz A; Mogilski S; Socała K; Nieoczym D; Szafarz M; Latacz G; Szulczyk B; Kalinowska-Tłuścik J; Gawel K; Esguerra CV; Wyska E; Müller CE; Bahar I; Fontana ACK; Wlaź P; Kamiński RM; Kamiński K
    J Med Chem; 2022 Sep; 65(17):11703-11725. PubMed ID: 35984707
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of tiagabine with valproate in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis for non-parallel dose-response relationship curves.
    Luszczki JJ; Krzyzanowski M; Swiader MJ
    Adv Med Sci; 2009; 54(1):75-81. PubMed ID: 19366650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic, antiallodynic, and anticonvulsant activity of novel hybrid molecules derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide in animal models of pain and epilepsy.
    Rapacz A; Kamiński K; Obniska J; Koczurkiewicz P; Pękala E; Filipek B
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):567-579. PubMed ID: 28188357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and anticonvulsant activity of new hybrid compounds derived from 2-(2,5-dioxopyrrolidin-1-yl)propanamides and 2-(2,5-dioxopyrrolidin-1-yl)butanamides.
    Kamiński K; Zagaja M; Łuszczki JJ; Rapacz A; Andres-Mach M; Latacz G; Kieć-Kononowicz K
    J Med Chem; 2015 Jul; 58(13):5274-86. PubMed ID: 26052884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and pharmacological evaluation of N-[4-(4-(alkyl/aryl/heteroaryl)-piperazin-1-yl)-phenyl]-carbamic acid ethyl ester derivatives as novel anticonvulsant agents.
    Kumari S; Mishra CB; Tiwari M
    Bioorg Med Chem Lett; 2015 Mar; 25(5):1092-9. PubMed ID: 25619635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
    Klitgaard H; Matagne A; Gobert J; Wülfert E
    Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional Hybrid Compounds Derived from 2-(2,5-Dioxopyrrolidin-1-yl)-3-methoxypropanamides with Anticonvulsant and Antinociceptive Properties.
    Abram M; Zagaja M; Mogilski S; Andres-Mach M; Latacz G; Baś S; Łuszczki JJ; Kieć-Kononowicz K; Kamiński K
    J Med Chem; 2017 Oct; 60(20):8565-8579. PubMed ID: 28934547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the impact of compound C11 a new anticonvulsant candidate on cognitive functions and hippocampal neurogenesis in mouse brain.
    Andres-Mach M; Szewczyk A; Zagaja M; Luszczki J; Maj M; Rola R; Abram M; Kaminski K
    Neuropharmacology; 2020 Feb; 163():107849. PubMed ID: 31706991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic and pharmacokinetic interactions of hydroalcoholic leaf extract of Centella asiatica with valproate and phenytoin in experimental models of epilepsy in rats.
    Kumar R; Arora R; Sarangi SC; Ganeshan N S; Agarwal A; Kaleekal T; Gupta YK
    J Ethnopharmacol; 2021 Apr; 270():113784. PubMed ID: 33429032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic and/or pharmacokinetic characteristics of interactions between loreclezole and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis.
    Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsy Behav; 2005 Dec; 7(4):639-51. PubMed ID: 16140589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric synthesis and in vivo/in vitro characterization of new hybrid anticonvulsants derived from (2,5-dioxopyrrolidin-1-yl)phenylacetamides.
    Abram M; Rapacz A; Latacz G; Szulczyk B; Kalinowska-Tłuścik J; Otto-Ślusarczyk D; Struga M; Kamiński RM; Kamiński K
    Bioorg Chem; 2021 Apr; 109():104751. PubMed ID: 33647745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sub-additive (antagonistic) interaction of lacosamide with lamotrigine and valproate in the maximal electroshock-induced seizure model in mice: an isobolographic analysis.
    Łuszczki JJ; Kondrat-Wróbel M; Zagaja M; Karwan S; Bojar H; Plewa Z; Florek-Łuszczki M
    Pharmacol Rep; 2020 Oct; 72(5):1288-1296. PubMed ID: 32507997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis.
    Luszczki JJ; Wojcik-Cwikla J; Andres MM; Czuczwar SJ
    Neuropsychopharmacology; 2005 May; 30(5):958-73. PubMed ID: 15525996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.